B. Dingle

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Timothy J. Whelan, Jim A. Julian, Tanya Berrang et al. · The Lancet · 2019 · 424 citations

Medicine, Oncology, Surgery +17

Acute nickel toxicity in electroplating workers who accidently ingested a solution of nickel sulfate and nickel chloride

F. William Sunderman, B. Dingle, Sidney M. Hopfer et al. · American Journal of Industrial Medicine · 1988 · 158 citations

Pharmacy, Clinical Toxicology, Toxicology +14

CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy

Wendy A. Teft, Inna Y. Gong, B. Dingle et al. · Breast Cancer Research and Treatment · 2013 · 78 citations

Medicine, Pharmacokinetics, Pharmacology +12

Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trial

Douglas A. Hoover, Dante P. I. Capaldi, Khadija Sheikh et al. · BMC Cancer · 2014 · 63 citations · Full text

Medicine, Oncology, Radiation Oncology +17